Bicomposite Nanotherapeutic Architecture for Pancreatic Ductal Adenocarcinoma (PDAC): Optimized 60 nm Series & Project60 Framework (v5.0)).

Moreno Sanchez-Campa, Jose Maria

Open source

DOI
10.5281/zenodo.21826884
Published
2026
Container
Not recorded
Publisher
Zenodo
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.21826884,
  title = {Bicomposite Nanotherapeutic Architecture for Pancreatic Ductal Adenocarcinoma (PDAC): Optimized 60 nm Series \& Project60 Framework (v5.0)).},
  author = {Moreno Sanchez-Campa, Jose Maria},
  year = {2026},
  doi = {10.5281/zenodo.21826884},
  url = {https://doi.org/10.5281/zenodo.21826884}
}

RIS

TY  - JOUR
TI  - Bicomposite Nanotherapeutic Architecture for Pancreatic Ductal Adenocarcinoma (PDAC): Optimized 60 nm Series & Project60 Framework (v5.0)).
AU  - Moreno Sanchez-Campa, Jose Maria
PY  - 2026
DO  - 10.5281/zenodo.21826884
UR  - https://doi.org/10.5281/zenodo.21826884
ER  - 

APA

Maria, M. S. J. (2026). Bicomposite Nanotherapeutic Architecture for Pancreatic Ductal Adenocarcinoma (PDAC): Optimized 60 nm Series & Project60 Framework (v5.0)).. https://doi.org/10.5281/zenodo.21826884

Source records